FGFR2 expression relates to subtype-specific tumour microenvironment (TIME) during luminal breast cancer evolution
{{output}}
Background: Fibroblast growth factor receptor 2 (FGFR2) is an oncogenic driver in luminal breast cancer (BCa), with emerging evidence linking it to tumour immune microenvironment (TIME) modulation. While FGFR2's role in endocrin... ...
